Literature DB >> 6520747

Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.

P Veng-Pedersen, W Gillespie.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6520747     DOI： 10.1007/bf01060131

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

3.  The pharmacokinetics of propylthiouracil.

Authors:  J Kampmann; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-11

4.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Computation of model-independent pharmacokinetic parameters during multiple dosing.

Authors:  M Chung
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

6.  Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

Authors:  D Perrier; M Mayersohn
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

7.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

9.  Pharmocokinetics of hexobarbital in man after intravenous infusion.

Authors:  D D Breimer; C Honhoff; W Zilly; E Richter; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

10.  Acceleration of the body clearance of phenobarbital by oral activated charcoal.

Authors:  M J Berg; W G Berlinger; M J Goldberg; R Spector; G F Johnson
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245
  10 in total
  15 in total

1.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

Review 2.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

3.  Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.

Authors:  C A Hunt; R D Macgregor; R A Siegel
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

4.  Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.

Authors:  K K Chan; M Gibaldi
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

Review 5.  Pharmacokinetics of recombinant bifunctional fusion proteins.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-20       Impact factor: 4.481

6.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

7.  Mean residence time in peripheral tissue.

Authors:  P J McNamara; J C Fleishaker; T L Hayden
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

8.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

9.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

10.  Mean residence time for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; G F Lockwood; L J Aarons; I D Abrahams
Journal:  J Pharmacokinet Biopharm       Date:  1989-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.